Direkt zum Inhalt | Direkt zur Navigation

Benutzerspezifische Werkzeuge

Sektionen
2012
Sie sind hier: Startseite / Publikationen / 2012

2012


 

Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, Mouquet H, Spatz LA, Diskin R, Abadir A, Zang T, Dorner M, Billerbeck E, Labitt RN, Gaebler C, Marcovecchio PM, Incesu RB, Eisenreich TR, Bieniasz PD, Seaman MS, Bjorkman PJ, Ravetch JV, Ploss A, Nussenzweig MC. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012; 492(7427): 118-22. PubMed

Pietzsch J, Gruell H, Bournazos S, Donovan BM, Klein F, Diskin R, Seaman MS, Bjorkman PJ, Ravetch JV, Ploss A, Nussenzweig MC. A mouse model for HIV-1 entry. Proc Natl Acad Sci U S A 2012; 109(39): 15859-64. PubMed

Schulmann K, Strate K, Pox CP, Wieland U, Kreuter A. Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma. J Clin Oncol 2012; 30(32): e325-6. PubMed

Scola N, Skrygan M, Wieland U, Kreuter A, Gambichler T. Altered gene expression in squamous cell carcinoma arising from congenital unilateral linear porokeratosis. Clin Exp Dermatol 2012; 37(7): 781-5. PubMed

Sather DN, Carbonetti S, Kehayia J, Kraft Z, Mikell I, Scheid JF, Klein F, Stamatatos L. Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virus. J Virol 2012; 86(23): 12676-85. PubMed

Buitrago-Perez A, Hachimi M, Duenas M, Lloveras B, Santos A, Holguin A, Duarte B, Santiago JL, Akgül B, Rodriguez-Peralto JL, Storey A, Ribas C, Larcher F, del Rio M, Paramio JM, Garcia-Escudero R. A humanized mouse model of HPV-associated pathology driven by E7 expression. PLoS One 2012; 7(7): e41743. PubMed

Sperling T, Oldak M, Walch-Ruckheim B, Wickenhauser C, Doorbar J, Pfister H, Malejczyk M, Majewski S, Keates AC, Smola S. Human papillomavirus type 8 interferes with a novel C/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration. PLoS Pathog 2012; 8(7): e1002833. PubMed

Fun A, Wensing AM, Verheyen J, Nijhuis M. Human Immunodeficiency Virus Gag and protease: partners in resistance. Retrovirology 2012; 9: 63. PubMed

Bozek K, Eckhardt M, Sierra S, Anders M, Kaiser R, Kräusslich HG, Müller B, Lengauer T. An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology 2012; 9: 60. PubMed

Klein F, Gaebler C, Mouquet H, Sather DN, Lehmann C, Scheid JF, Kraft Z, Liu Y, Pietzsch J, Hurley A, Poignard P, Feizi T, Morris L, Walker BD, Fatkenheuer G, Seaman MS, Stamatatos L, Nussenzweig MC. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J Exp Med 2012; 209(8): 1469-79. PubMed

Scola N, Wieland U, Silling S, Altmeyer P, Stucker M, Kreuter A. Prevalence of human polyomaviruses in common and rare types of non-Merkel cell carcinoma skin cancer. Br J Dermatol 2012; 167(6): 1315-20. PubMed

Kaiser R, Wensing AM. HIV co-receptor tropism: old target for new therapeutic strategies. Curr Opin HIV AIDS 2012; 7(5): 429-31. PubMed

Potthoff A, Wieland U, Kreuter A. Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency. Arch Dermatol 2012; 148(5): 659-60. PubMed

Mikolajczak S, Quante G, Weissenborn S, Wafaisade A, Wieland U, Luers JC, Klussmann JP, Beutner D. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2012; 269(12): 2543-8. PubMed

Beggel B, Neumann-Fraune M, Doring M, Lawyer G, Kaiser R, Verheyen J, Lengauer T. Genotyping hepatitis B virus dual infections using population-based sequence data. J Gen Virol 2012; 93(Pt 9): 1899-907. PubMed

Schmitt M, Wieland U, Kreuter A, Pawlita M. C-terminal deletions of Merkel cell polyomavirus large T-antigen, a highly specific surrogate marker for virally induced malignancy. Int J Cancer 2012; 131(12): 2863-8. PubMed

Lazic D, Hufbauer M, Zigrino P, Buchholz S, Kazem S, Feltkamp MC, Mauch C, Steger G, Pfister H, Akgül B. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2. J Virol 2012; 86(15): 7943-52. PubMed

Verheyen J, Neumann-Fraune M, Berg T, Kaiser R, Obermeier M. The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. J Clin Virol 2012; 54(3): 279-81. PubMed

Rhee SY, Blanco JL, Liu TF, Pere I, Kaiser R, Zazzi M, Incardona F, Towner W, Gatell JM, De Luca A, Fessel WJ, Shafer RW. Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes. AIDS Res Ther 2012; 9(1): 13. PubMed

Verheyen J, Kaiser R, Bozic M, Timmen-Wego M, Maier BK, Kessler HH. Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms. J Clin Virol 2012; 54(3): 255-9. PubMed

Akgül B, Zigrino P, Hufbauer M, Liu X, Moore PS, Mauch C, Pfister H. Lack of integrin beta5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus positivity. J Dermatol Sci 2012; 67(1): 66-8. PubMed

Rappl G, Riet T, Awerkiew S, Schmidt A, Hombach AA, Pfister H, Abken H. The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells. PLoS One 2012; 7(1): e30713. PubMed

Oette M, Schülter E, Rosen-Zvi M, Peres Y, Zazzi M, Sonnerborg A, Struck D, Altmann A, Kaiser R. Efficacy of antiretroviral therapy switch in HIV-infected patients: a 10-year analysis of the EuResist Cohort. Intervirology 2012; 55(2): 160-6. PubMed

Oette M, Reuter S, Kaiser R, Lengauer T, Fatkenheuer G, Knechten H, Hower M, Pfister H, Haussinger D. Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009. Intervirology 2012; 55(2): 154-9. PubMed

Zazzi M, Incardona F, Rosen-Zvi M, Prosperi M, Lengauer T, Altmann A, Sonnerborg A, Lavee T, Schülter E, Kaiser R. Predicting response to antiretroviral treatment by machine learning: the EuResist project. Intervirology 2012; 55(2): 123-7. PubMed

Obermeier M, Pironti A, Berg T, Braun P, Däumer M, Eberle J, Ehret R, Kaiser R, Kleinkauf N, Korn K, Kücherer C, Müller H, Noah C, Stürmer M, Thielen A, Wolf E, Walter H. HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge. Intervirology 2012; 55(2): 102-7. PubMed

Sierra-Aragon S, Walter H. Targets for inhibition of HIV replication: entry, enzyme action, release and maturation. Intervirology 2012; 55(2): 84-97. PubMed

Wieland U, Stuecker M, Kreuter A. HPV vaccine against anal intraepithelial neoplasia. N Engl J Med 2012; 366(4): 378; author reply -9. PubMed

Lawyer G, Schülter E, Kaiser R, Reuter S, Oette M, Lengauer T. Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort. Med Microbiol Immunol 2012; 201(3): 259-69. PubMed

Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. J Clin Virol 2012; 53(4): 325-31. PubMed

Borgogna C, Zavattaro E, De Andrea M, Griffin HM, Dell'Oste V, Azzimonti B, Landini MM, Peh WL, Pfister H, Doorbar J, Landolfo S, Gariglio M. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology 2012; 423(2): 195-204. PubMed

Knops E, Brakier-Gingras L, Schülter E, Pfister H, Kaiser R, Verheyen J. Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors. Med Microbiol Immunol 2012; 201(2): 213-8. PubMed

Vehreschild JJ, Moritz G, Vehreschild MJ, Arenz D, Mahne M, Bredenfeld H, Chemnitz J, Klein F, Cremer B, Boll B, Kaul I, Wassmer G, Hallek M, Scheid C, Cornely OA. Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. Int J Antimicrob Agents 2012; 39(2): 130-4. PubMed

Vehreschild JJ, Brockelmann PJ, Bangard C, Verheyen J, Vehreschild MJ, Michels G, Wisplinghoff H, Cornely OA. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol Infect 2012; 140(10): 1848-52. PubMed

Svicher V, Cento V, Bernassola M, Neumann-Fraune M, Van Hemert F, Chen M, Salpini R, Liu C, Longo R, Visca M, Romano S, Micheli V, Bertoli A, Gori C, Ceccherini-Silberstein F, Sarrecchia C, Andreoni M, Angelico M, Ursitti A, Spano A, Zhang JM, Verheyen J, Cappiello G, Perno CF. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res 2012; 93(1): 86-93. PubMed

Wieland U, Scola N, Stolte B, Stucker M, Silling S, Kreuter A. No evidence for a causal role of Merkel cell polyomavirus in keratoacanthoma. J Am Acad Dermatol 2012; 67(1): 41-6. PubMed

Kreuter A, Bechara FG, Stucker M, Brockmeyer NH, Altmeyer P, Wieland U. Perianal basal cell carcinoma - unusual localization of a frequent tumor. J Dtsch Dermatol Ges 2012; 10(1): 59-61. PubMed

Sampogna F, Bavinck JN, Pawlita M, Abeni D, Harwood CA, Proby CM, Feltkamp MC, Euvrard S, Naldi L, Neale RE, Nindl I, Pfister H, Quint WG, Waterboer T. Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients. J Gen Virol 2012; 93(Pt 1): 165-74. PubMed

Akgül B, Pfister D, Knuchel R, Heidenreich A, Wieland U, Pfister H. No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients. Med Microbiol Immunol 2012; 201(2): 245-8. PubMed

Weissenborn S, Neale RE, Waterboer T, Abeni D, Bavinck JN, Green AC, Harwood CA, Euvrard S, Feltkamp MC, de Koning MN, Naldi L, Quint WG, Tessari G, Proby CM, Wieland U, Pfister H. Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol 2012; 201(2): 117-25. PubMed

Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H. Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med Microbiol Immunol 2012; 201(1): 17-23. PubMed

Heger E, Thielen A, Gilles R, Obermeier M, Lengauer T, Kaiser R, Trapp S. APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1. Med Microbiol Immunol 2012; 201(1): 7-16. PubMed